Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LEVOMILNACIPRAN Cause Abdominal pain upper? 285 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 285 reports of Abdominal pain upper have been filed in association with LEVOMILNACIPRAN (Fetzima). This represents 20.7% of all adverse event reports for LEVOMILNACIPRAN.

285
Reports of Abdominal pain upper with LEVOMILNACIPRAN
20.7%
of all LEVOMILNACIPRAN reports
148
Deaths
103
Hospitalizations

How Dangerous Is Abdominal pain upper From LEVOMILNACIPRAN?

Of the 285 reports, 148 (51.9%) resulted in death, 103 (36.1%) required hospitalization, and 103 (36.1%) were considered life-threatening.

Is Abdominal pain upper Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LEVOMILNACIPRAN. However, 285 reports have been filed with the FAERS database.

What Other Side Effects Does LEVOMILNACIPRAN Cause?

Off label use (376) Drug ineffective (315) Gastrooesophageal reflux disease (295) Vomiting (294) Hypoaesthesia (290) Paraesthesia (282) Memory impairment (277) Blepharospasm (276) Taste disorder (276) Drug intolerance (275)

What Other Drugs Cause Abdominal pain upper?

ADALIMUMAB (7,337) METHOTREXATE (5,096) ETANERCEPT (4,570) APREMILAST (4,404) TOFACITINIB (4,225) ACETAMINOPHEN (3,879) TOCILIZUMAB (3,876) LEFLUNOMIDE (3,390) ABATACEPT (3,365) NAPROXEN (3,265)

Which LEVOMILNACIPRAN Alternatives Have Lower Abdominal pain upper Risk?

LEVOMILNACIPRAN vs LEVONORGESTREL LEVOMILNACIPRAN vs LEVORPHANOL LEVOMILNACIPRAN vs LEVOSIMENDAN LEVOMILNACIPRAN vs LEVOSULPIRIDE LEVOMILNACIPRAN vs LEVOTHYROXINE

Related Pages

LEVOMILNACIPRAN Full Profile All Abdominal pain upper Reports All Drugs Causing Abdominal pain upper LEVOMILNACIPRAN Demographics